CSF3R and central nervous system cancer: Analysis of glioma patient OS in relation to CSF3R/CD114 transcript levels in tumors showed that, when all glioma types were pooled together, higher CSF3R/CD114 expression was significantly associated with a poorer prognosis as assessed by shorter OS (Figure 2A).